CHICAGO (GenomeWeb) – BC Platforms, a Swiss genomic data management company, announced today that it has raised $10 million in a Series B funding round. The Debiopharm Innovation Fund, of Lausanne, Switzerland, and Finnish private equity company Tesi led the investment.

BC Platforms said it plans on using the funding in part to add a clinical component this year to its existing software for genomic data management. The company has a goal of managing genomic and clinical data of at least 5 million people by 2020, drawn from biobanks around the world.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.